Andrea Hayes-Jordan, MD, FACS, FAAP
Andrea Hayes-Jordan, MD, FACS, FAAP, a pioneering surgeon and researcher, has been named Chief of the Division of Pediatric Surgery at the University of North Carolina (UNC) School of Medicine and Surgeon-in-Chief at the North Carolina Children’s Hospital. She officially joined the UNC School of Medicine faculty in June 2018.
Dr. Hayes-Jordan came to Chapel Hill from The University of Texas MD Anderson Cancer Center in Houston, where she served as Director of Pediatric Surgery and Pediatric Oncology. She also served as Residency Program Director and Pediatric Surgical Oncology Fellowship Director.
“I am thrilled to be joining the Tar Heel family and look forward to leading the UNC Children’s Hospital to a bright future in continued excellent service to the children of North Carolina,” said Dr. Hayes-Jordan.
“We are incredibly fortunate to have Dr. Hayes-Jordan join us at UNC,” said Melina R. Kibbe, MD, Colin G. Thomas Jr. Distinguished Professor and Chair of the Department of Surgery. “She is an outstanding role model to all who work with her and exemplifies all three missions of our academic medical center.”
Clinical and Research Accomplishments
An internationally recognized leader in pediatric surgery and pediatric oncology, Dr. Hayes-Jordan was the first African American female pediatric surgeon board certified in the United States. She was the first surgeon to perform cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a pediatric patient. As the surgeon who pioneered this procedure, Dr. Hayes-Jordan has treated patients from across the globe and traveled extensively in the United States and abroad, teaching it to other surgeons.
In addition to her clinical accomplishments, Dr. Hayes-Jordan is noted as both a basic science and clinical researcher. In her laboratory, she focuses on the study of rare sarcomas. She has developed a first-of-its-kind mouse model that duplicates human desmoplastic small round cell tumor, allowing scientists for the first time to study the disease in an animal model that replicates the spread of tumors seen in human patients. In the clinical setting, Dr. Hayes-Jordan studies refractory sarcomas and has conducted clinical trials establishing the proper dosage of chemotherapy for children receiving hyperthermic intraperitoneal chemotherapy. ■
